Induction of energy metabolism related enzymes in yeast Saccharomyces cerevisiae exposed to ibogaine is adaptation to acute decrease in ATP energy pool

European Journal of Pharmacology

Volumn 627, Issue 1-3, 2010, Pages 131-135

  Paškulin, Roman ^a   Jamnik, Polona ^b   Obermajer, Nataša ^b,c   Slavić, Marija ^d   Štrukelj, Borut ^b  

^a OMI Institute   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Addiction therapy; Energy metabolism; Ibogaine; Proteomics; Tabernanthe iboga; Yeast

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALCOHOL DEHYDROGENASE; ENOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IBOGAINE; PHOSPHOGLYCERATE KINASE;

ADAPTATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY METABOLISM; ENZYME INDUCTION; ENZYME SYNTHESIS; FUNGUS GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE; TISSUE SPECIFICITY;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE TRIPHOSPHATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; ENZYME INDUCTION; GENE EXPRESSION REGULATION, FUNGAL; IBOGAINE; ORGAN SPECIFICITY; REACTIVE OXYGEN SPECIES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SPECIES SPECIFICITY;

EID: 73549109863     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.10.032     Document Type: Article

References (27)

1. Ali S.F., Newport G.D., Slikker Jr. W., Rothman R.B., and Baumann M.H. Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation. Brain Res. 737 (1996) 215-220
2. Ali S.F., Thiriet N., and Zwiller J. Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain. Brain Res. Mol. Brain Res. 74 (1999) 237-241
3. Alper K.R. Ibogaine: a review. Alkaloids, Chem. Biol. 56 (2001) 1-38
4. Alper K.R., Lotsof H.S., Frenken G.M., Luciano D.J., and Bastiaans J. Treatment of acute opioid withdrawal with ibogaine. Am. J. Addict. 8 (1999) 234-242
5. Alper K.R., Lotsof H.S., and Kaplan C.D. The ibogaine medical subculture. J. Ethnopharmacol. 115 (2008) 9-24
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Carnicella S., Kharazia V., Jeanblanc J., Janak P.H., and Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8114-8119
8. Glick S.D., Maisonneuve I.M., Kitchen B.A., and Fleck M.W. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur. J. Pharmacol. 438 (2002) 99-105
9. Görg A. Two-dimensional electrophoresis. Nature 349 (1991) 545-546
10. Hakkiwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 4th ed. (2007), Oxford University Press, New York
11. He D.Y., McGough N.N., Ravindranathan A., Jeanblanc J., Logrip M.L., Phamluong K., Janak P.H., and Ron D. Glial cell line-derived neutrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J. Neurosci. 25 (2005) 619-628
12. Jakubowski W., and Bartosz G. Estimation of oxidative stress in Saccharomyces cerevisiae with fluorescent probes. Int. J. Biochem. Cell Biol. 11 (1997) 1297-1301
13. Jamnik P., Medved P., and Raspor P. Increased glutathione content in yeast Saccharomyces cerevisiae exposed to NaCl. Ann. Microbiol. 56 2 (2006) 175-178
14. Kontrimaviciute V., Mathieu O., Mathieu-Daude J., Vainauskas P., Casper T., Baccino E., and Bressolle F.M.M. Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub. J. Anal. Toxicol. 30 (2006) 434-440
15. Leal M.B., Michelin K., Souza D.O., and Elisabetsky E. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 781-785
16. Li C.-Y., Mao X., and Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput. Biol. 4 (2008) 28-34
17. Lotsof H.S. The Ibogaine Dossier (2007). http://www.ibogaine.org URL: http://www.ibogaine.org (accessed 1.6.2009)
18. Ma D. Applications of yeast in drug discovery. Prog. Drug Res. 57 (2001) 117-162
19. Maciulaitis R., Kontrimaviciute V., Bressolle F.M., and Briedis V. Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review. Human Exp. Toxicol. 27 (2008) 181-194
20. Mash D.C., Kovera C.A., Pablo J., Tyndale R.F., Ervin F.D., Willwams I.C., Singleton E.G., and Mayor M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann. N. Y. Acad. Sci. 914 (2000) 394-401
21. Menacho-Marquez M., and Murguia J.R. Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research. Clin. Transl. Oncol. 9 (2007) 221-228
22. Onaivi E.S., Ali S.F., Chirwa S.S., Zwiller J., Thiriet N., Akinshola B.E., and Ishiguro H. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Ann. N. Y. Acad. Sci. 965 (2002) 28-46
23. Paškulin R., Jamnik P., Živin M., Raspor P., and Štrukelj B. Ibogaine affects brain energy metabolism. Eur. J. Pharmacol. 552 (2006) 11-14
24. Ryman B.E., and Walsh E.O. Some effects of cocaine on the metabolism of Saccharomyces cerevisiae. Biochem. J. 50 (1952) 570-573
25. Sadava D., Alonso D., Hong H., and Pettit-Barrett D.P. Effect of methadone addiction on glucose metabolism in rats. Gen. Pharmacol. 28 (1997) 27-29
26. Sharma S.K., Yashpal K., Fundytus M.E., Sauriol F., Henry J.L., and Coderre T.J. Alternations in brain metabolism by chronic morphine treatment: NMR studies in rat CNS. Neurchem. Res. 28 (2003) 1369-1373
27. Walker G.M. Yeast Physiology and Biotechnology (1998), Wiley&Sons, Chichester